Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,226 | 32 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $622.88 | 19 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $141.93 | 1 | $0 (2023) |
| Alkermes, Inc. | $120.00 | 1 | $0 (2022) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $103.27 | 1 | $0 (2023) |
| Indivior Inc. | $73.61 | 3 | $0 (2023) |
| ABBVIE INC. | $34.26 | 1 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $33.41 | 2 | $0 (2023) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $29.00 | 1 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $27.19 | 1 | $0 (2023) |
| ITI, Inc. | $23.79 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $427.52 | 18 | Janssen Pharmaceuticals, Inc ($348.08) |
| 2023 | $391.51 | 8 | Ferring Pharmaceuticals Inc. ($141.93) |
| 2022 | $146.57 | 2 | Alkermes, Inc. ($120.00) |
| 2021 | $259.92 | 4 | Janssen Pharmaceuticals, Inc ($248.23) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $5.35 | General |
| Category: Neuroscience | ||||||
| 11/11/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Neuroscience | ||||||
| 11/07/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Neurology | ||||||
| 10/29/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $44.27 | General |
| Category: Neuroscience | ||||||
| 08/26/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $33.08 | General |
| Category: Neuroscience | ||||||
| 08/21/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Neuroscience | ||||||
| 07/22/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: Neuroscience | ||||||
| 07/17/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Neuroscience | ||||||
| 06/28/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $8.33 | General |
| Category: Neuroscience | ||||||
| 06/27/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $31.41 | General |
| Category: Neuroscience | ||||||
| 05/29/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $6.75 | General |
| Category: Neuroscience | ||||||
| 05/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.26 | General |
| Category: NEUROSCIENCE | ||||||
| 05/15/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Neuroscience | ||||||
| 05/09/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Neuroscience | ||||||
| 04/23/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $37.39 | General |
| Category: Neuroscience | ||||||
| 04/12/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $32.33 | General |
| Category: Neuroscience | ||||||
| 03/29/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: Neuroscience | ||||||
| 03/19/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $29.00 | General |
| 12/06/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $27.19 | General |
| Category: Neuropsychiatry | ||||||
| 10/11/2023 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $141.93 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/06/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: PSYCHIATRY | ||||||
| 08/14/2023 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $28.03 | General |
| Category: BH | ||||||
| 07/25/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: PSYCHIATRY | ||||||
| 07/20/2023 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: BH | ||||||
| 04/28/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $103.27 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 672 | 2,265 | $580,829 | $144,126 |
| 2022 | 5 | 636 | 2,860 | $448,010 | $214,375 |
| 2021 | 7 | 805 | 3,450 | $458,271 | $187,766 |
| 2020 | 6 | 144 | 401 | $62,788 | $28,636 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 352 | 1,687 | $416,801 | $95,062 | 22.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 68 | 252 | $56,925 | $21,352 | 37.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 85 | 88 | $38,500 | $10,640 | 27.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 16 | 77 | $23,100 | $5,355 | 23.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 86 | 90 | $27,000 | $5,226 | 19.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 38 | 40 | $12,718 | $3,701 | 29.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 18 | $4,680 | $2,223 | 47.5% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Facility | 2023 | 11 | 13 | $1,105 | $566.93 | 51.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 394 | 2,582 | $387,425 | $189,663 | 49.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 90 | 98 | $24,750 | $12,200 | 49.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 85 | 107 | $22,600 | $5,539 | 24.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 35 | 38 | $10,260 | $5,396 | 52.6% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Facility | 2022 | 32 | 35 | $2,975 | $1,577 | 53.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 454 | 3,001 | $373,921 | $156,395 | 41.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 227 | 274 | $48,925 | $14,511 | 29.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 57 | 59 | $15,200 | $7,378 | 48.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 19 | 64 | $9,600 | $4,656 | 48.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 18 | 21 | $5,625 | $3,058 | 54.4% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Facility | 2021 | 19 | 20 | $1,700 | $914.40 | 53.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 11 | 11 | $3,300 | $853.80 | 25.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 30 | 173 | $25,950 | $13,321 | 51.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 42 | 152 | $18,692 | $8,126 | 43.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 19 | 21 | $5,670 | $3,136 | 55.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 20 | 22 | $6,600 | $1,754 | 26.6% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2020 | 12 | 12 | $2,076 | $1,158 | 55.8% |
About Reeva Bazroy, PMHNP
Reeva Bazroy, PMHNP is a Psychiatric/Mental Health healthcare provider based in Artesia, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2018. The National Provider Identifier (NPI) number assigned to this provider is 1811474349.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Reeva Bazroy, PMHNP has received a total of $1,226 in payments from pharmaceutical and medical device companies, with $427.52 received in 2024. These payments were reported across 32 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,226).
As a Medicare-enrolled provider, Bazroy has provided services to 2,257 Medicare beneficiaries, totaling 8,976 services with total Medicare billing of $574,904. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Location Artesia, CA
- Active Since 07/26/2018
- Last Updated 07/26/2018
- Taxonomy Code 363LP0808X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1811474349
Products in Payments
- INVEGA SUSTENNA (Drug) $498.05
- REBYOTA (Biological) $141.93
- INVEGA TRINZA (Drug) $124.83
- LYBALVI (Drug) $120.00
- LifeVest (Device) $103.27
- PERSERIS (Drug) $73.61
- VRAYLAR (Drug) $34.26
- INGREZZA (Drug) $27.19
- CAPLYTA (Drug) $23.79
- ABILIFY ASIMTUFII (Drug) $21.72
- UZEDY (Drug) $16.18
- ABILIFY MAINTENA (Drug) $11.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Artesia
Carlos Olivas, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $1,047
Mrs. Tammy Sherrell, Cnp, CNP
Psychiatric/Mental Health — Payments: $55.99
Dr. Davin Craig, Dnp, Pmhnp-Bc, DNP, PMHNP-BC
Psychiatric/Mental Health — Payments: $53.85
Dr. Michael Parr, Dnp, Pmhnp-Bc, DNP, PMHNP-BC
Psychiatric/Mental Health — Payments: $16.06
Susan Caley, Cnp, CNP
Psychiatric/Mental Health — Payments: $12.35
Ms. Susan Lowe, Rn,Np, RN,NP
Psychiatric/Mental Health